about
Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence?Letrozole increases ovarian growth and Cyp17a1 gene expression in the rat ovary.Cetrotide administration in the early luteal phase in patients at high risk of ovarian hyperstimulation syndrome: A controlled clinical study.Polycystic ovary syndrome: chemical pharmacotherapy.The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders.Breast cancer risk after exposure to fertility drugs.No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology.Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response.Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study.Controlled ovarian hyperstimulation with sequential letrozole co-treatment in normo/high responders.Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.Extraovarian gonadotropin negative feedback revealed by aromatase inhibition in female marmoset monkeys.Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study
P2860
Q28066722-E119A86C-8674-4C24-9839-CF8786C902E9Q30414520-00C50E5C-3E45-46C6-85BC-F1016EDABB0CQ34443933-22AEEF2B-57C9-43BD-8943-4B3481368168Q35639510-6B296A1E-5669-4E8E-9A54-F06B90A11154Q35707971-78C6A0A6-2786-45FF-88B9-ED9DFE1316F2Q38081240-43C515C9-C828-4F5D-BAE7-12DC3684D270Q38404583-08193E32-84AD-43CD-B836-901BCAC68CD5Q38897852-1D89E7C1-95D0-4D9E-9009-9CE23D4A9A8BQ40278645-82761FDC-B183-4A5B-8C5C-47DFC2B75453Q40408159-3B25884F-4C4C-439D-8333-D02D3B1CCB26Q44312594-A69E073D-B41E-45BE-B0B2-4E6F05411410Q47708954-069348AE-F252-479D-9F89-F78EF546DDF7Q48618463-3EAD3C67-05BB-4AE2-A90F-76B1AA5D1A46Q50949601-C6C68674-9902-4C55-A076-DDC3072C03BFQ58741803-A272A0AE-7B01-4C53-A155-A7DD2E1C3521
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Aromatase inhibitors in stimulated IVF cycles.
@ast
Aromatase inhibitors in stimulated IVF cycles.
@en
type
label
Aromatase inhibitors in stimulated IVF cycles.
@ast
Aromatase inhibitors in stimulated IVF cycles.
@en
prefLabel
Aromatase inhibitors in stimulated IVF cycles.
@ast
Aromatase inhibitors in stimulated IVF cycles.
@en
P2093
P2860
P921
P356
P1476
Aromatase inhibitors in stimulated IVF cycles
@en
P2093
Basil Tarlatzis
Ernesto Bosch
Evangelos G Papanikolaou
George Pados
Nikolaos P Polyzos
P2860
P2888
P356
10.1186/1477-7827-9-85
P577
2011-06-21T00:00:00Z
P5875
P6179
1040668525